Delivery Order SPE2D021DA002-SPE2D326F3854
- Not listed
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,045.50 to DMS Pharmaceutical Group Inc. for epinephrine 0.3 mg auto-injector supplies (two-pack). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected through firm fixed-price procurement with no set-aside designation, demonstrating the company's competitive capability in unrestricted federal contracting. The delivery...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $2,091.00 to DMS Pharmaceutical Group Inc. for epinephrine 0.3 mg auto-injector supplies on January 7, 2026, with completion scheduled for January 8, 2026. This firm fixed-price delivery order was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $2,613.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract was awarded on December 12, 2025, with an ultimate completion date of December 15, 2025, under a firm fixed-price arrangement with no set-aside designation. This delivery order was issued under DMS...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $1,219.75 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector units. The contract, issued on January 12, 2026, with an ultimate completion date of January 13, 2026, was awarded on a firm fixed-price basis without set-aside designation, demonstrating the contractor's competitive...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,661.80 to DMS Pharmaceutical Group Inc. for epinephrine auto-injectors on October 23, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation under a firm fixed-price delivery order contract type. The awardee has demonstrated substantial federal contracting activity as a...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $1,279.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector sets. This firm fixed-price delivery order, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, was awarded without set-aside designation, reflecting the contractor's competitive capability in...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $3,833.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector 2-packs. The award, issued on October 16, 2025, with an ultimate completion date of October 17, 2025, was made without a set-aside designation, demonstrating the vendor's competitive capability in unrestricted...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,394.00 to DMS Pharmaceutical Group Inc. for the supply of epinephrine 0.3 mg auto-injector pens (two-pack). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order carries a firm...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,515.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector units. The delivery order was issued on December 16, 2025, with an ultimate completion date of December 17, 2025, and carries no set-aside designation, indicating the award was made through open competition. This delivery order is...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This firm fixed-price delivery order, valued at $2,590.25, was awarded on November 26, 2025, with completion scheduled for November 28, 2025. The award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D326F3854Delivery Order
The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,394.00 to DMS Pharmaceutical Group Inc. for epinephrine 0.3 mg auto-injector two-packs on January 14, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected through firm fixed-price pricing with no set-aside designation. The delivery order falls under the company's existing Indefinite Delivery Contract with the Defense Logistics Agency, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which represents a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for Department of Defense healthcare operations. DMS Pharmaceutical Group's prime vendor contract, awarded in November 2025 with a ceiling value of $499,999,999 and completion date of December 31, 2036, authorizes the Defense Logistics Agency to issue delivery orders for a comprehensive range of pharmaceutical products and medical consumables to support military healthcare facilities worldwide. The company's established capability in distributing emergency medications, specialty pharmaceuticals, biologics, and routine drugs across multiple therapeutic categories has positioned it as a critical supplier within the federal pharmaceutical supply chain. The epinephrine auto-injector delivery order represents routine procurement activity under this broader contracting vehicle, with completion targeted for January 15, 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/13/26 |